TMEM170B and breast carcinoma: To determine whether TMEM170B expression levels are related to the clinical breast cancer progression, we analyzed the association between TMEM170B and the clinicopathological status of breast cancer patients in the TCGA cohort (Supplementary Tables 1 and 2) and cohort 2 (Supplementary Table 3).